Philips Medical System’s latest contribution to brain scanning is its high-field MR system, the 3 tesla Gyroscan Intera. The system is under development with the University of Zurich in Switzerland, but Philips previewed the system and some of
Philips Medical Systems latest contribution to brain scanning is its high-field MR system, the 3 tesla Gyroscan Intera. The system is under development with the University of Zurich in Switzerland, but Philips previewed the system and some of its features at this months Organization for Human Brain Mapping meeting in San Antonio.
The improved signal-to-noise ratio of a stronger field scanner will assist brain mapping efforts through enhanced standard imaging, MR spectroscopy, diffusion, perfusion, and functional MR techniques, according to clinicians involved with the scanner. The 3-tesla system is a part of Philips Intera product line.
Along with the scanner, Philips highlighted SENSE, an ultra-fast imaging technique also being developed with the University of Zurich.
By doubling the scanning speed, SENSE will improve a wide range of MR studies, according to the firm.
Philips is also working on a method called DTI, or diffusion tensor imaging. DTI detects how white matter fiber tracts connect different parts of the brain.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.